MEDICLIN AG reported group earnings results for the first quarter ended March 31, 2018. For the quarter, the company achieved Group sales of EUR 157.7 million, which were EUR 10.6 million or 7.2 % higher than in the previous year's quarter. Group EBIT improved by EUR 1.2 million from LBIT of EUR 0.5 million to EUR 0.7 million. The total consolidated result attributable to shareholders of the company was EUR 0.2 million compared to loss of EUR 0.8 million a year ago. Gross investments amounted to EUR 9.5 million in the first quarter of the 2018 financial year compared to EUR 11.2 million a year ago pertaining mainly to the reconstruction and expansion of clinics and the acquisition of medical equipment. Capital expenditure is thus in line with the annual budget.